20-year trends in cause-specific heart failure outcomes by sex, socioeconomic status, and place of diagnosis: a population-based study

Claire A Lawson, Francesco Zaccardi, Iain Squire, Suping Ling, Melanie J Davies, Carolyn S P Lam, Mamas A Mamas, Kamlesh Khunti, Umesh T Kadam, Claire A Lawson, Francesco Zaccardi, Iain Squire, Suping Ling, Melanie J Davies, Carolyn S P Lam, Mamas A Mamas, Kamlesh Khunti, Umesh T Kadam

Abstract

Background: Heart failure is an important public health issue affecting about 1 million people in the UK, but contemporary trends in cause-specific outcomes among different population groups are unknown.

Methods: In this retrospective, population-based study, we used the UK Clinical Practice Research Datalink and Hospital Episodes Statistics databases to identify a cohort of patients who had a diagnosis of incident heart failure between Jan 1, 1998, and July 31, 2017. Patients were eligible for inclusion if they were aged 30 years or older with a first code for heart failure in their primary care or hospital record during the study period. We assessed cause-specific admission to hospital (ie, hospitalisation) and mortality, by age, sex, socioeconomic status, and place of diagnosis (ie, hospital vs community diagnosis). We calculated outcome rates separately for the first year (first-year rates) and for the second-year onwards (subsequent-year rates). Patients were followed up until death or study end. This study is registered with Clinical Practice Research Datalink Independent Scientific Advisory Committee, protocol number 18_037R.

Findings: We identified 88 416 individuals with incident heart failure over the study period, of whom 43 461 (49%) were female. The mean age was 77·8 years (SD 11·3) and median follow-up was 2·4 years (IQR 0·5 to 5·7). Age-adjusted first-year rates of hospitalisation increased by 28% for all-cause admissions, from 97·1 (95% CI 94·3 to 99·9) to 124·2 (120·9 to 127·5) per 100 person-years; by 28% for heart failure-specific admissions, from 17·2 (16·2 to 18·2) to 22·1 (20·9 to 23·2) per 100 person-years; and by 42% for non-cardiovascular admissions, from 59·2 (57·2 to 61·2) to 83·9 (81·3 to 86·5) per 100 person-years. 167 641 (73%) of 228 113 hospitalisations were for non-cardiovascular causes and annual rate increases were higher for women (3·9%, 95% CI 2·8 to 4·9) than for men (1·4%, 0·6 to 2·1; p<0·0001); and for patients diagnosed with heart failure in hospital (2·4%, 1·4 to 3·3) than those diagnosed in the community (1·2%, 0·3 to 2·2). Annual increases in hospitalisation due to heart failure were 2·6% (1·9 to 3·4) for women compared with stable rates in men (0·6%, -0·9 to 2·1), and 1·6% (0·6 to 2·6) for the most deprived group compared with stable rates for the most affluent group (1·2%, -0·3 to 2·8). A significantly higher risk of all-cause hospitalisation was found for the most deprived than for the most affluent (incident rate ratio 1·34, 95% CI 1·32 to 1·35) and for the hospital-diagnosed group than for the community-diagnosed group (1·76, 1·73 to 1·80). Age-adjusted first-year rates of all-cause mortality decreased by 6% from 24·5 (95% CI 23·4 to 39·2) to 23·0 (22·0 to 24·1) per 100 person-years. Annual change in mortality was -1·4% (95% CI -2·3 to -0·5) in men but was stable for women (0·3%, -0·5 to 1·1), and -2·7% (-3·2 to -2·2) for the community-diagnosed group compared with -1·1% (-1·8 to -0·4) in the hospital-diagnosed group (p<0·0001). A significantly higher risk of all-cause mortality was seen in the most deprived group than in the most affluent group (hazard ratio 1·08, 95% CI 1·05 to 1·11) and in the hospital-diagnosed group than in the community-diagnosed group (1·55, 1·53 to 1·58).

Interpretation: Tailored management strategies and specialist care for patients with heart failure are needed to address persisting and increasing inequalities for men, the most deprived, and for those who are diagnosed with heart failure in hospital, and to address the worrying trends in women.

Funding: Wellcome Trust.

Copyright © 2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.

Figures

Figure 1
Figure 1
Predicted rates of cause-specific hospitalisation during the first year after heart failure diagnosis, by population group Data are predicted hospitalisation rates, estimated at the mean population age (77·8 years), per 100 person-years by cause, between 1998 and 2015. Whiskers are 95% CIs. Hospitalisations included all non-elective admissions with at least one overnight stay and occurring after but not including the date of heart failure diagnosis. Follow-up was until death or study end.
Figure 2
Figure 2
First-year rates of mortality, by population group and calendar year of diagnosis Data are predicted rates of mortality per 100 person-years at mean population age (77·8 years) per 100 person-years between 1998 and 2015. Whiskers are 95% CIs. Rates were calculated in survivors of the first month after heart failure diagnosis.

References

    1. Bui AL, Horwich TB, Fonarow GC. Epidemiology and risk profile of heart failure. Nat Rev Cardiol. 2011;8:30–41.
    1. Townsend N, Bhatnagar P, Wilkins E, Wickramasinghe K, Rayner M. British Heart Foundation; London: Dec 8, 2015. Cardiovascular disease statistics.
    1. Ponikowski P, Voors AA, Anker SD. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37:2129–2200.
    1. Mamas MA, Sperrin M, Watson MC. Do patients have worse outcomes in heart failure than in cancer? A primary care-based cohort study with 10-year follow-up in Scotland. Eur J Heart Fail. 2017;19:1095–1104.
    1. Gerber Y, Weston SA, Redfield MM. A contemporary appraisal of the heart failure epidemic in Olmsted County, Minnesota, 2000 to 2010. JAMA Intern Med. 2015;175:996–1004.
    1. Akwo EA, Kabagambe EK, Wang TJ. Heart failure incidence and mortality in the southern community cohort study. Circ Heart Fail. 2017;10
    1. Witte KK, Patel PA, Walker AMN. Socioeconomic deprivation and mode-specific outcomes in patients with chronic heart failure. Heart. 2018;104:993–998.
    1. Cook C, Cole G, Asaria P, Jabbour R, Francis DP. The annual global economic burden of heart failure. Int J Cardiol. 2014;171:368–376.
    1. Benjamin EJ, Blaha MJ, Chiuve SE. Heart Disease and Stroke Statistics—2017 update: a report from the American Heart Association. Circulation. 2017;135:e146–e603.
    1. Schocken DD, Benjamin EJ, Fonarow GC. Prevention of heart failure: a scientific statement from the American Heart Association Councils on Epidemiology and Prevention, Clinical Cardiology, Cardiovascular Nursing, and High Blood Pressure Research; Quality of Care and Outcomes Research Interdisciplinary Working Group; and Functional Genomics and Translational Biology Interdisciplinary Working Group. Circulation. 2008;117:2544–2565.
    1. Chen J, Normand ST, Wang Y, Krumholz HM. National and regional trends in heart failure hospitalization and mortality rates for Medicare beneficiaries, 1998–2008. JAMA. 2011;306:1669–1678.
    1. Chang PP, Wruck LM, Shahar E. Trends in hospitalizations and survival of acute decompensated heart failure in four US communities (2005–2014): ARIC study community surveillance. Circulation. 2018;138:12–24.
    1. Christiansen MN, Kober L, Weeke P. Age-specific trends in incidence, mortality, and comorbidities of heart failure in Denmark, 1995 to 2012. Circulation. 2017;135:1214–1223.
    1. Taylor CJ, Ordóñez-Mena JM, Roalfe AK. Trends in survival after a diagnosis of heart failure in the United Kingdom 2000–2017: population based cohort study. BMJ. 2019;364:l223.
    1. Roger VL, Weston SA, Redfield MM. Trends in heart failure incidence and survival in a community-based population. JAMA. 2004;292:344–350.
    1. Herrett E, Gallagher AM, Bhaskaran K. Data resource profile: clinical practice research datalink (CPRD) Int J Epidemiol. 2015;44:827–836.
    1. Maru S, Koch GG, Stender M. Antidiabetic drugs and heart failure risk in patients with type 2 diabetes in the U.K. primary care setting. Diabetes Care. 2005;28:20–26.
    1. Department for Communities and Local Government; London: 2011. The English indices of deprivation 2010.
    1. Valente MA, Hillege HL, Navis G. The Chronic Kidney Disease Epidemiology Collaboration equation outperforms the modification of diet in renal disease equation for estimating glomerular filtration rate in chronic systolic heart failure. Eur J Heart Fail. 2014;16:86–94.
    1. Rea F, Pagan E, Compagnoni M. Joinpoint regression analysis with time-on-study as time-scale. Application to three Italian population-based cohort studies. Epidemiol Biostat Public Health. 2017;14:e12616-1–e12616-8.
    1. Putter H, Fiocco M, Geskus RB. Tutorial in biostatistics: competing risks and multi-state models. Stat Med. 2007;26:2389–2430.
    1. Rubin DB. Wiley; New York, NY: 1987. Multiple imputation for nonresponse in surveys.
    1. Levy D, Kenchaiah S, Larson MG. Long-term trends in the incidence of and survival with heart failure. N Engl J Med. 2002;347:1397–1402.
    1. Roger VL, Weston SA, Redfield MM. Trends in heart failure incidence and survival in a community-based population. JAMA. 2004;292:344–350.
    1. Jhund PS, Macintyre K, Simpson CR. Long-term trends in first hospitalization for heart failure and subsequent survival between 1986 and 2003: a population study of 5.1 million people. Circulation. 2009;119:515–523.
    1. Schmidt M, Ulrichsen SP, Pedersen L, Bøtker HE, Sorensen HT. Thirty-year trends in heart failure hospitalization and mortality rates and the prognostic impact of co-morbidity: a Danish nationwide cohort study. Eur J Heart Fail. 2016;18:490–499.
    1. Shah A, Udeoji D, Baraghoush A, Bharadwaj P, Yennurajalingam S, Schwarz ER. An evaluation of the prevalence and severity of pain and other symptoms in acute decompensated heart failure. J Palliat Med. 2013;16:87–90.
    1. Sun LY, Tu JV, Sherrard H. Sex-specific trends in incidence and mortality for urban and rural ambulatory heart failure patients in eastern Ontario from 1994 to 2013. J Card Fail. 2018;24:568–574.
    1. Koudstaal S, Pujades-Rodriguez M, Denaxas S. Prognostic burden of heart failure recorded in primary care, acute hospital admissions, or both: a population-based linked electronic health record cohort study in 2.1 million people. Eur J Heart Fail. 2017;19:1119–1127.
    1. National Institute for Cardiovascular Outcomes Research (NICOR) University College London, National Institute for Cardiovascular Outcomes Research; London: 2018. National Heart Failure Audit 2016/17 summary report.
    1. Acute heart failure: failure to function. London: National Confidential Enquiry into Patient Outcome and Death. Nov 22, 2018.
    1. Bottle A, Kim D, Aylin P, Cowie MR, Majeed A, Hayhoe B. Routes to diagnosis of heart failure: observational study using linked data in England. Heart. 2018;104:600–605.
    1. Gerber Y, Weston SA, Enriquez-Sarano M. Mortality associated with heart failure after myocardial infarction: a contemporary community perspective. Circ Heart Fail. 2016;9
    1. Bhatia RS, Tu JV, Lee DS. Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med. 2006;355:260–269.
    1. Hawkins NM, Jhund PS, McMurray JJ, Capewell S. Heart failure and socioeconomic status: accumulating evidence of inequality. Eur J Heart Fail. 2012;14:138–146.
    1. McAlister FA, Murphy NF, Simpson CR. Influence of socioeconomic deprivation on the primary care burden and treatment of patients with a diagnosis of heart failure in general practice in Scotland: population based study. BMJ. 2004;328:1110.
    1. Exarchakou A, Rachet B, Belot A, Maringe C, Coleman MP. Impact of national cancer policies on cancer survival trends and socioeconomic inequalities in England, 1996–2013: population based study. BMJ. 2018;360:k764.
    1. Gillam S, Steel N. The Quality and Outcomes Framework—where next? BMJ. 2013;346:f659.

Source: PubMed

3
Abonnere